Perkins Capital Management Inc Vericel Corp Transaction History

Perkins Capital Management Inc

  • $90.7 Million
  • Q2 2025

A detailed history of Perkins Capital Management Inc transactions in Vericel Corp stock. As of the latest transaction made, Perkins Capital Management Inc holds 26,100 shares of VCEL stock, worth $876,699. This represents 1.22% of its overall portfolio holdings.

Number of Shares
26,100
Previous 26,600 1.88%
Holding current value
$876,699
Previous $1.19 Million 6.41%
% of portfolio
1.22%
Previous 1.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$37.92 - $45.7 $18,960 - $22,850
-500 Reduced 1.88%
26,100 $1.11 Million
Q1 2025

May 07, 2025
SELL
$44.5 - $61.8 $46,725 - $64,890
-1,050 Reduced 3.8%
26,600 $1.19 Million
Q4 2024

Feb 11, 2025
SELL
$40.05 - $59.11 $64,079 - $94,576
-1,600 Reduced 5.47%
27,650 $1.52 Million
Q3 2024

Oct 31, 2024
SELL
$42.25 - $53.56 $84,500 - $107,120
-2,000 Reduced 6.4%
29,250 $1.24 Million
Q4 2023

Jan 22, 2024
SELL
$30.85 - $37.09 $23,137 - $27,817
-750 Reduced 2.34%
31,250 $1.11 Million
Q3 2023

Nov 02, 2023
SELL
$31.69 - $39.25 $27,475 - $34,029
-867 Reduced 2.64%
32,000 $1.07 Million
Q2 2023

Jul 21, 2023
SELL
$29.0 - $38.37 $29,000 - $38,370
-1,000 Reduced 2.95%
32,867 $1.24 Million
Q1 2023

May 09, 2023
SELL
$23.85 - $31.34 $52,470 - $68,948
-2,200 Reduced 6.1%
33,867 $993,000
Q4 2022

Jan 26, 2023
SELL
$17.65 - $27.37 $5,295 - $8,211
-300 Reduced 0.82%
36,067 $950,000
Q2 2022

Jul 29, 2022
SELL
$22.88 - $39.45 $27,456 - $47,340
-1,200 Reduced 3.19%
36,367 $916,000
Q1 2022

Apr 20, 2022
SELL
$31.69 - $43.29 $477,568 - $652,380
-15,070 Reduced 28.63%
37,567 $1.44 Million
Q4 2021

Feb 10, 2022
SELL
$35.2 - $52.6 $800,800 - $1.2 Million
-22,750 Reduced 30.18%
52,637 $2.07 Million
Q3 2021

Oct 25, 2021
SELL
$46.35 - $59.75 $149,478 - $192,693
-3,225 Reduced 4.1%
75,387 $3.68 Million
Q2 2021

Jul 28, 2021
SELL
$47.2 - $67.81 $3.61 Million - $5.19 Million
-76,495 Reduced 49.32%
78,612 $4.13 Million
Q1 2021

Apr 28, 2021
SELL
$30.93 - $59.48 $3.03 Million - $5.82 Million
-97,930 Reduced 38.7%
155,107 $8.62 Million
Q4 2020

Feb 09, 2021
SELL
$18.53 - $31.5 $442,125 - $751,590
-23,860 Reduced 8.62%
253,037 $7.81 Million
Q3 2020

Oct 28, 2020
SELL
$14.68 - $19.12 $990,900 - $1.29 Million
-67,500 Reduced 19.6%
276,897 $5.13 Million
Q1 2020

Apr 29, 2020
SELL
$7.25 - $19.22 $66,337 - $175,863
-9,150 Reduced 2.59%
344,397 $3.16 Million
Q4 2019

Feb 03, 2020
SELL
$13.77 - $19.2 $625,846 - $872,640
-45,450 Reduced 11.39%
353,547 $6.15 Million
Q3 2019

Oct 23, 2019
SELL
$14.93 - $19.83 $417,338 - $554,307
-27,953 Reduced 6.55%
398,997 $6.04 Million
Q2 2019

Aug 09, 2019
SELL
$15.01 - $18.89 $873,582 - $1.1 Million
-58,200 Reduced 12.0%
426,950 $8.07 Million
Q1 2019

Apr 22, 2019
SELL
$16.23 - $20.29 $972,177 - $1.22 Million
-59,900 Reduced 10.99%
485,150 $8.5 Million
Q4 2018

Feb 11, 2019
SELL
$10.77 - $18.44 $50,619 - $86,668
-4,700 Reduced 0.85%
545,050 $9.48 Million
Q3 2018

Oct 22, 2018
SELL
$9.1 - $14.8 $21,385 - $34,780
-2,350 Reduced 0.43%
549,750 $7.78 Million
Q2 2018

Aug 02, 2018
BUY
$9.6 - $14.6 $68,640 - $104,390
7,150 Added 1.31%
552,100 $5.36 Million
Q1 2018

Apr 23, 2018
SELL
$5.7 - $12.3 $193,800 - $418,200
-34,000 Reduced 5.87%
544,950 $5.42 Million
Q4 2017

Jan 26, 2018
BUY
$3.65 - $5.98 $59,677 - $97,773
16,350 Added 2.91%
578,950 $3.16 Million
Q3 2017

Oct 31, 2017
BUY
$3.0 - $6.0 $1.69 Million - $3.38 Million
562,600
562,600 $3.38 Million

Others Institutions Holding VCEL

# of Institutions
293
Shares Held
54M
Call Options Held
35.6K
Put Options Held
7.7K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.58B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email